Safety and Cognitive Function Study of EVP-6124 in Patients With Mild to Moderate Alzheimer's Disease

NCT01073228 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

409

Enrollment

INDUSTRY

Sponsor class

Conditions

Alzheimer's Disease
Central Nervous System Diseases
Cognition

Interventions

DRUG: EVP-6124
DRUG: Placebo

Sponsor

FORUM Pharmaceuticals Inc

Collaborators

[object Object]